Mendelian Genetics: Multiple Alleles, Blood Groups, and Hereditary Pathologies

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/31

flashcard set

Earn XP

Description and Tags

Vocabulary practice flashcards focusing on Mendelian genetics, multiple allelism in AB0 blood groups, molecular mechanisms of dominance and recessiveness, penetrance, expressivity, and X-linked neuromuscular disorders.

32 Terms

1
New cards

AB0 Blood Group System

A human blood group system determined by three multiple alleles of the same gene (IAI^A, IBI^B, and ii) resulting in six possible genotypes and four distinct phenotypes (AA, BB, ABAB, and 00).

2
New cards

Codominance

A genetic relationship in which both alleles are simultaneously and fully expressed in the heterozygote without one masking the other, producing a 1:2:11 : 2 : 1 phenotypic ratio in a monohybrid cross of two heterozygotes (e.g., the IAIBI^AI^B genotype expressing both AA and BB antigens).

3
New cards

Complete Dominance

A mode of inheritance where the dominant allele completely masks the recessive allele in heterozygotes, resulting in a 3:13 : 1 phenotypic ratio and a 1:2:11 : 2 : 1 genotypic ratio from a cross between two heterozygotes (Aa×AaAa \times Aa).

4
New cards

Incomplete Dominance

An inheritance pattern in which the heterozygous individual manifests an intermediate phenotype between the two homozygotes, yielding a 1:2:11 : 2 : 1 phenotypic ratio (e.g., pink flowers resulting from red and white flowering plants).

5
New cards

Universal Donor (AB0)

An individual belonging to blood group 00 who possesses neither AA nor BB surface antigens on their red blood cells and can donate red blood cells to all AB0 blood groups.

6
New cards

Universal Recipient (AB0)

An individual with blood group ABAB whose plasma contains neither anti-A nor anti-B antibodies, allowing them to receive red blood cells from groups AA, BB, ABAB, and 00 in the AB0 system.

7
New cards

Sickle Cell Anemia

An inherited autosomal recessive disease caused by a variant in the HBB gene encoding beta-globin, producing hemoglobin S (HbSHbS) that polymerizes under deoxygenated conditions and deforms red blood cells into a sickle shape.

8
New cards

Sickle Cell Trait

The heterozygous state (HbA/HbSHbA/HbS) in which an individual produces both normal hemoglobin A and hemoglobin S; such individuals generally do not exhibit sickle cell anemia but may experience complications under severe hypoxia or dehydration.

9
New cards

Beta-Thalassemia

A group of hereditary disorders resulting from variants in the HBB gene that decrease or completely prevent the production of beta-globin chains in hemoglobin.

10
New cards

Compound Heterozygote

An individual who carries two distinct pathogenic variants within the same gene, one on each homologous chromosome, which can cause clinical manifestation of an autosomal recessive condition.

11
New cards

Autosomal Recessive Inheritance

A transmission pattern where a genetic disorder typically manifests only when both copies of an autosomal gene harbor pathogenic variants, frequently operating via a loss-of-function molecular mechanism.

12
New cards

Autosomal Dominant Inheritance

A mode of inheritance in which the presence of a single pathogenic allele on an autosome is sufficient to manifest the disease phenotype in heterozygotes, often characterized by vertical transmission across generations.

13
New cards

De Novo Mutation

A new genetic alteration arising spontaneously in a germ cell or during early embryonic development, resulting in a dominant disorder appearing in an individual with unaffected parents.

14
New cards

Gain of Function

A dominant pathogenic mechanism whereby a mutated protein acquires a novel activity or exhibits excessive, constitutive, or dysregulated normal activity (e.g., FGFR3 in achondroplasia, HTT in Huntington chorea, and oncogenes).

15
New cards

Dominant Negative Effect

A molecular mechanism where a mutant protein actively interferes with the function or structural assembly of the normal protein produced by the wild-type allele (e.g., fibrillin-1 encoded by FBN1 in Marfan syndrome).

16
New cards

Haploinsufficiency

A condition in dominant disorders where a single functional copy of a gene produces an insufficient amount of protein (approximately 50%50\% of normal levels) to preserve a wild-type phenotype (e.g., Waardenburg syndrome).

17
New cards

Penetrance

The proportion of individuals carrying a specific genotype who actually display the associated recognizable clinical phenotype.

18
New cards

Incomplete Penetrance

A genetic phenomenon in which some individuals who possess a pathogenic genotype fail to express the corresponding clinical phenotype.

19
New cards

Variable Expressivity

Variation in the degree, severity, symptoms, or specific organ manifestations of a genetic condition among individuals sharing the same pathogenic genotype (e.g., Marfan syndrome).

20
New cards

Thermolabile Tyrosinase

A temperature-sensitive enzyme variant in Siamese cats that loses catalytic activity at higher core body temperatures but retains function at cooler extremities, leading to localized melanin synthesis in ears, paws, snout, and tail.

21
New cards

Phenylketonuria (PKU)

An autosomal recessive inborn error of metabolism caused by variants impairing phenylalanine hydroxylase (PAH), leading to neurotoxic accumulation of phenylalanine that can be effectively managed with a low-phenylalanine diet.

22
New cards

Epigenetic Modifications

Heritable or stable regulatory mechanisms, such as DNA methylation and histone modifications, that modulate gene expression levels without altering the underlying nucleotide sequence of DNA.

23
New cards

CFTR

An ATP-regulated ABC transporter family protein acting as an epithelial ion channel for chloride and bicarbonate ions; pathogenic variants in its gene disrupt epithelial fluid balance, causing cystic fibrosis.

24
New cards

Genetic Heterogeneity

The biological occurrence where mutations in different, independent genes give rise to the same or very similar clinical phenotypes, as exemplified by various oculocutaneous forms of albinism.

25
New cards

Hemizygosity

The genetic state of possessing only a single copy of a gene or chromosome segment, which is normal for males (XYXY) regarding genes located on the X chromosome.

26
New cards

Morgan's Drosophila Experiment

Thomas Hunt Morgan's breeding crosses demonstrating X-linkage using white-eyed mutant fruit flies, revealing that all F1F_1 offspring had red eyes while in the F2F_2 generation the white-eye phenotype appeared exclusively in males.

27
New cards

Dystrophin

A structural protein localized to the inner surface of the sarcolemma that anchors the internal cytoskeleton to membrane protein complexes and the extracellular matrix, stabilizing muscle fibers during contraction.

28
New cards

Reading-Frame Rule

The molecular principle stating that out-of-frame variants in the DMD gene disrupt translation to yield no functional dystrophin (Duchenne), while in-frame variants permit the production of an internally shortened, partially functional protein (Becker).

29
New cards

Duchenne Muscular Dystrophy (DMD)

A severe X-linked recessive neuromuscular disease caused by DMD gene variants that completely abolish functional dystrophin, characterized by early childhood onset and rapid, progressive muscle degeneration.

30
New cards

Becker Muscular Dystrophy (BMD)

An X-linked recessive muscular dystrophy caused by DMD gene variants that result in a structurally altered or reduced quantity of dystrophin that retains partial function, leading to a later onset and slower progression than Duchenne.

31
New cards

Barr Body

The dense, condensed structure formed by the largely transcriptional inactivated X chromosome in female mammalian somatic cell nuclei.

32
New cards

Skewed X-Inactivation

A non-random pattern of X-chromosome inactivation where the normal X chromosome is silenced in an unusually high proportion of cells, potentially causing female carriers of X-linked recessive variants to present clinical symptoms.